Infant Bacterial Therapeutics AB - Class B

NEW
OSTO:IBT B (Sweden)   Class B
kr 65 +1.4 (+2.2%) Sep 14
At Loss
P/B:
16.52
Market Cap:
kr 875.64M ($ 89.84M)
Enterprise V:
kr 767.04M ($ 78.69M)
Volume:
1.80K
Avg Vol (2M):
7.94K
Trade In:
Volume:
1.80K
At Loss
Avg Vol (2M):
7.94K

Infant Bacterial Therapeutics AB (OSTO:IBT B) Dividend

Infant Bacterial Therapeutics AB (OSTO:IBT B) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -6.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: OSTO:IBT B Dividend

Does Infant Bacterial Therapeutics AB (OSTO:IBT B) pay a dividend?

Infant Bacterial Therapeutics AB (OSTO:IBT B) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Infant Bacterial Therapeutics AB pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Infant Bacterial Therapeutics AB has returned capital to shareholders via buybacks at a rate of -6.3% over the past 3 years.

What are dividend-paying alternatives to Infant Bacterial Therapeutics AB?

For dividend-paying alternatives in Infant Bacterial Therapeutics AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.